The Central Drug Standard Control Organisation (CDSCO) vide notification dated 24.05.2021, informed that Government of India has revised clinical guidance for management of Adult COVID-19 patients on 19.05.2021.
“Convalescent plasma” (off label) as investigational therapy has been taken out of the clinical management protocol.
The Securities and Exchange Board of India (SEBI) has released a consultation paper proposing an increase in the size criteria under the additional disclosure framework
On January 10, 2025, SEBI released a circular detailing a revised and revamped framework for nomination facilities in demat accounts and mutual fund (MF) folios.
SEBI has delegated the power to waive or reduce the interest levied only in respect of recovery proceedings initiated for failure to pay penalty, to
These amendments align with IRDAI’s broader goals of transitioning toward a modern, principle-based regulatory framework. They aim to streamline the conduct of meetings, enhance participation,
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
